Piramal Pharma Limited Free Cash Flow Generation Index
Piramal Pharma Limited free cash flow generation index. Piramal Pharma Limited (PPLPHARMA) has a Free Cash Flow Generation Index of 0.51x as of September 2025. Free cash flow of Rs4.57 Billion represents 1% of operating cash flow (Rs8.90 Billion). Check Piramal Pharma Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Piramal Pharma Limited (2021–2026)
Free cash flow generation index of Piramal Pharma Limited from 2021 to 2026. Historical FCF Generation Index trend for Piramal Pharma Limited across 6 annual periods. Explore PPLPHARMA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Piramal Pharma Limited Free Cash Flow Generation Index by Year (2021–2026)
Piramal Pharma Limited free cash flow generation index by year from 2021 to 2026. Year-by-year Free Cash Flow Generation Index for Piramal Pharma Limited. For the full cash flow conversion analysis, see PPLPHARMA cash generation efficiency.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.36x | Rs5.10 Billion | Rs14.00 Billion | Rs8.90 Billion | ▲ +42.5% |
| 2025 | 0.26x | Rs2.28 Billion | Rs8.92 Billion | Rs6.64 Billion | ▼ -12.3% |
| 2024 | 0.29x | Rs2.92 Billion | Rs10.05 Billion | Rs7.12 Billion | ▲ +129.3% |
| 2023 | -0.99x | Rs-4.81 Billion | Rs4.84 Billion | Rs9.65 Billion | ▼ -563.7% |
| 2022 | 0.21x | Rs546.90 Million | Rs2.55 Billion | Rs2.01 Billion | ▲ +131.8% |
| 2021 | -0.67x | Rs-233.90 Million | Rs347.20 Million | Rs581.10 Million | — |